0 items
Your cart is empty.
99.2% On-Time Delivery
Tracked International Shipping
Refund Within 28 Days
Secure, Encrypted Checkout
Each peptide batch is tested and verified to meet or exceed 98–99% purity (HPLC).
Store 2–8 °C (≤–20 °C long-term). RT exposure during transport acceptable. Protect from light.
99.2% On-Time Delivery
Tracked International Shipping
Refund Within 28 Days
Secure, Encrypted Checkout
$97.00
This product is available by prescription only
This product does not require a prescription
Out Of Stock
Each peptide batch is tested and verified to meet or exceed 98–99% purity (HPLC).
Store 2–8 °C (≤–20 °C long-term). RT exposure during transport acceptable. Protect from light.
The product is delivered in powdered (lyophilized) form and must be properly reconstituted prior to research use.
GLOW is a research peptide blend composed of three experimentally studied peptide sequences: GHK-Cu, BPC-157, and TB-500 (Thymosin Beta-4 fragment). The formulation is supplied for laboratory research examining peptide signaling interactions and multi-compound pathway investigation.
This combination format allows researchers to investigate peptide interactions across different signaling domains within controlled experimental systems. The blend may be used in studies exploring extracellular matrix dynamics, peptide–cell signaling interactions, and receptor pathway modulation.
Each batch is analytically verified through Certificate of Analysis (COA) documentation confirming molecular identity and purity of the peptide components.
This compound blend is supplied exclusively for laboratory research.
Research involving peptide blends may explore interactions across multiple cellular signaling pathways.
Published research involving the individual peptide components includes investigation of:
Studies involving peptide combinations may examine pathway cross-talk or comparative signaling responses within controlled in vitro systems.
All references relate strictly to experimental laboratory research.
GLOW peptide blend is supplied as a lyophilized powder.
Recommended handling procedures include:
All experimental procedures should follow institutional research protocols.
Each production batch undergoes analytical verification procedures including:
These procedures support consistent analytical standards for research applications.
Sequence and molecular specifications for each component are provided in batch documentation.
Novera Research delivers high-quality research peptides developed under strict manufacturing and quality-control standards. Each product is carefully synthesized, tested, and handled to ensure consistency, reliability, and transparency for advanced research applications.
High-purity, research-grade peptide synthesis
Analytical testing to verify quality and composition
Consistent batch-to-batch performance
Batch identification on every vial for traceability
Stored and shipped under controlled conditions
Research-grade synthetic thymic peptide formulated in 10mg quantity for immune peptide studies and thymosin mechanism research in controlled laboratory environments.
Research-grade synthetic dual-peptide formulation combining amylin analog and GLP-1 receptor agonist for dual-mechanism pathway studies and combination peptide research in controlled laboratory environments.
A synthetic GHRH analog studied for receptor binding kinetics, molecular interaction modeling, and pulsatile signaling pathway investigation in preclinical settings.
Research-grade synthetic nonapeptide supplied in 5mg format for controlled in vitro laboratory investigation.
A synthetic aromatic-cationic tetrapeptide studied for selective inner mitochondrial membrane localization, cardiolipin binding dynamics, and oxidative phosphorylation pathway marker activity in controlled in-vitro and preclinical models.
